Kymera Therapeutics (KYMR) Prepaid Assets (2019 - 2026)

Kymera Therapeutics' (KYMR) quarterly Prepaid Assets came in at $26.5 million in Q1 2026, up 48.88% year-on-year from $17.8 million in Q1 2025, and up 15.54% on a QoQ basis from $22.9 million in Q4 2025.

Kymera Therapeutics (KYMR) Prepaid Assets (2019 - 2026) Analysis & Trends

Kymera Therapeutics (KYMR) has 8 years of Prepaid Assets data on file, last reported at $26.5 million in Q1 2026.

  • On a quarterly basis, Prepaid Assets rose 48.88% year-over-year to $26.5 million in Q1 2026; TTM through Mar 2026 was $26.5 million, a 48.88% increase from a year earlier, with the FY2025 full-year figure at $22.9 million, up 6.57% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $26.5 million, up from $22.9 million in the prior quarter.
  • Over the last five years, Prepaid Assets for KYMR reached as high as $26.5 million in Q1 2026 and fell as low as $8.1 million in Q2 2022.
  • Historically, Prepaid Assets has averaged $15.7 million across 5 years, with a median of $14.1 million in 2023.
  • On a YoY basis, Prepaid Assets climbed as much as 84.38% in 2024 and fell as far as 0.32% in 2024.
  • Year by year, Prepaid Assets stood at $9.7 million in 2022, then gained by 20.19% to $11.7 million in 2023, then jumped by 84.38% to $21.5 million in 2024, then grew by 6.57% to $22.9 million in 2025, then grew by 15.54% to $26.5 million in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $26.5 million in Q1 2026, $22.9 million in Q4 2025, and $22.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Kymera Therapeutics 10.77 Bn 10.11 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 26.50 Mn
Dec 31, 2025 22.94 Mn
Sep 30, 2025 22.62 Mn
Jun 30, 2025 22.88 Mn
Mar 31, 2025 17.80 Mn
Dec 31, 2024 21.52 Mn
Sep 30, 2024 17.43 Mn
Jun 30, 2024 13.75 Mn
Mar 31, 2024 14.68 Mn
Dec 31, 2023 11.67 Mn
Sep 30, 2023 14.09 Mn
Jun 30, 2023 13.71 Mn
Mar 31, 2023 11.35 Mn
Dec 31, 2022 9.71 Mn
Sep 30, 2022 9.23 Mn
Jun 30, 2022 8.09 Mn
Mar 31, 2022 9.31 Mn
Dec 31, 2021 8.72 Mn
Sep 30, 2021 5.77 Mn
Jun 30, 2021 4.80 Mn